Substance P, Pain, and Neuroinflammation in Glaucoma

This audio article is from VisualFieldTest.com.Read the full article here: https://visualfieldtest.com/en/substance-p-pain-and-neuroinflammation-in-glaucomaTest your visual field online: https://visualfieldtest.comSupport the show so new episodes keep coming: https://www.buzzsprout.com/2563091/supportExcerpt:Substance P, Pain, and Neuroinflammation in Glaucoma Glaucoma is a chronic eye disease that damages the optic nerve and can lead to vision loss. Many people with glaucoma also suffer from ocular surface discomfort – redness, burning, or dryness of the eye – especially if they use eye drops or have surgery. These symptoms are not only uncomfortable, but they can make it harder to stick to glaucoma treatment. Researchers have discovered that Substance P – a small protein (neuropeptide) released by nerve endings – plays a key role in eye pain and inflammation. Understanding how Substance P works may help us treat these symptoms. This article explains Substance P’s role in eye inflammation and pain, why that matters for glaucoma patients, and what studies tell us about drugs that block this pathway. Importantly, we distinguish easing symptoms (like dryness or pain relief) from protecting vision (slowing the nerve damage in glaucoma). Substance P and Neuroinflammation Substance P (SP) is a signaling molecule made by nerve cells. When nerves are irritated or injured, they release Substance P into the surrounding tissue. Substance P then binds to its receptor (called the neurokinin-1 receptor, or NK1R) on nearby cells. This triggers several effects: blood vessels in the tissue expand and become leaky, immune cells (like white blood cells) are recruited, and inflammatory chemicals (cytokines) are released (). In simple terms, Substance P tells the body, “Something’s wrong here – send help!” This process is called neurogenic inflammation. It helps fight infection or heal damage, but it also causes redness, swelling, and pain. For example, in the cornea (the clear front of the eye), Substance P causes blood vessels to dilate and immune cells to come in (). It also directly amplifies pain signals by acting on nerve fibers (Aδ and C fibers) that carry pain to the brain (). Because the cornea is one of the most heavily-innervated tissues in the body, it can produce and respond to a lot of Substance P () (). Normally, a small amount of SP helps regulate tear production and blink reflexes (). But after injury or chronic irritation (such as allergic or dry eye), SP levels can surge. High SP can make the cornea and conjunctiva (the white part of the eye) much more sensitive and inflamed. In experiments, blocking SP’s action strongly reduces inflammation: nerves that lack the SP receptor show fewer immune cells arrive, and mice missing SP themselves have less swelling () (). In other words, Substance P turns up the inflammation—and pain—in the eye. Why Substance P Matters for Glaucoma and Ocular Discomfort Glaucoma itself is characterized by loss of retinal ganglion cells (RGCs) in the back of the eye (the retina). However, many people with glaucoma experience ocular surface symptoms unrelated to vision: dryness, burning, soreness, or red eyes. These often come from eye drop preservatives or inflammation from surgeries, and they can involve Substance P. For example, irritating drops or foreign substances on the eye surface make corneal nerves release more SP (), which then increases inflammation and pain. Studies show that when the ocular surface is inflamed, trigeminal nerves (the ones sensing the eye) begin to express much more Substance P () (). This creates a vicious cycle: dry or injured eyes produce SP, SP causes more inflammation and nerve sensitization, which tSupport the show